EXPRESS ZERTIFIKAT - BAYER | Market Closed - Deutsche Boerse AG 01:33:05 2024-05-17 pm EDT | ||
| 412.2 EUR | -0.25% |
|
| Current month | +4.51% | ||
| 1 month | +9.06% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 412.2 | -0.25% |
| 24-05-16 | 413.2 | -3.00% |
| 24-05-15 | 426 | -0.10% |
| 24-05-14 | 426.4 | -1.14% |
| 24-05-13 | 431.3 | +1.97% |
Delayed Quote Deutsche Boerse AG
Last update May 17, 2024 at 01:33 pm EDT
More quotesStatic data
| Product type | Other Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BAYER AG |
| Issuer | 
UniCredit
|
| WKN | HVB3XQ |
| ISIN | DE000HVB3XQ5 |
| Date issued | 2019-11-19 |
| Strike | 70.43 € |
| Maturity | 2024-11-15 (182 Days) |
| Parity | 0.07 : 1 |
| Emission price | 1,000 € |
| Emission volume | N/A |
| Settlement | both |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1,171 € |
|---|---|
| Lowest since issue | 366.8 € |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
28.58
EUR
Average target price
36.9
EUR
Spread / Average Target
+29.13%
- Stock Market
- Certificates
- Certificat